Total Payments
$15,253
2022 Payments
$132.14
Companies
34
Transactions
107
Medicare Patients
1,395
Medicare Billing
$167,976
Payment Breakdown by Category
Consulting$13,187 (86.5%)
Food & Beverage$1,689 (11.1%)
Travel$227.75 (1.5%)
Education$149.86 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,187 | 7 | 86.5% |
| Food and Beverage | $1,689 | 93 | 11.1% |
| Travel and Lodging | $227.75 | 3 | 1.5% |
| Education | $149.86 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $3,423 | 4 | $0 (2018) |
| PFIZER INC. | $3,383 | 7 | $0 (2019) |
| TerSera Therapeutics LLC | $2,622 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $2,067 | 2 | $0 (2021) |
| Seagen Inc. | $1,367 | 2 | $0 (2022) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $735.17 | 8 | $0 (2021) |
| Foundation Medicine, Inc. | $303.90 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $162.35 | 10 | $0 (2017) |
| Astellas Pharma US Inc | $156.26 | 9 | $0 (2018) |
| Genentech USA, Inc. | $142.15 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $132.14 | 2 | Seagen Inc. ($117.49) |
| 2021 | $3,930 | 3 | AstraZeneca Pharmaceuticals LP ($2,055) |
| 2019 | $3,354 | 5 | PFIZER INC. ($3,309) |
| 2018 | $6,493 | 20 | GENZYME CORPORATION ($3,423) |
| 2017 | $1,344 | 77 | Janssen Biotech, Inc. ($162.35) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/07/2022 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: BioOncology | ||||||
| 03/09/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $117.49 | General |
| Category: Oncology | ||||||
| 12/02/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 11/16/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | KISQALI (Drug) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2021 | Seagen Inc. | PADCEV (Biological) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Oncology | ||||||
| 12/09/2019 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $59.04 | General |
| 11/14/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 08/30/2019 | Clinigen Inc | Proleukin (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Metastatic Renal Cell Carcinoma or Melanoma | ||||||
| 06/13/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Endocrinology | ||||||
| 05/31/2019 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 10/24/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Consulting Fee | Cash or cash equivalent | $3,270.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $87.16 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Travel and Lodging | Cash or cash equivalent | $53.96 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: BioOncology | ||||||
| 07/11/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Endocrinology | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONACT (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Consulting Fee | Cash or cash equivalent | $114.75 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Travel and Lodging | Cash or cash equivalent | $114.75 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONACT (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Food and Beverage | Cash or cash equivalent | $37.20 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2018 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID (Device), FOUNDATIONFOCUS, FOUNDATIONONE CDX | Food and Beverage | Cash or cash equivalent | $37.20 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.47 | General |
| 03/28/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: BioOncology | ||||||
| 03/23/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Oncology | ||||||
| 02/26/2018 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 02/22/2018 | PFIZER INC. | SUTENT (Drug), INLYTA, IBRANCE | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 398 | 685 | $293,243 | $56,785 |
| 2021 | 6 | 459 | 684 | $278,026 | $58,073 |
| 2020 | 7 | 538 | 745 | $220,114 | $53,118 |
Total Patients
1,395
Total Services
2,114
Medicare Billing
$167,976
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 288 | 562 | $232,704 | $42,316 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $28,152 | $6,561 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 49 | $21,183 | $5,494 | 25.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $7,200 | $1,781 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $4,004 | $634.32 | 15.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 266 | 450 | $189,207 | $35,009 | 18.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 73 | $28,777 | $8,484 | 29.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 52 | 52 | $29,342 | $7,873 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 73 | $18,623 | $3,566 | 19.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $7,650 | $1,965 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 19 | $4,427 | $1,176 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 241 | 390 | $109,590 | $23,893 | 21.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 98 | 119 | $44,506 | $10,998 | 24.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 54 | 54 | $28,944 | $7,605 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 109 | $17,881 | $5,294 | 29.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 21 | 29 | $4,785 | $1,607 | 33.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $4,950 | $1,314 | 26.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 14 | 14 | $5,236 | $1,204 | 23.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 19 | $4,222 | $1,203 | 28.5% |
About Dr. Robert Somer, MD
Dr. Robert Somer, MD is a Hematology & Oncology healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285725267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Somer, MD has received a total of $15,253 in payments from pharmaceutical and medical device companies, with $132.14 received in 2022. These payments were reported across 107 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($13,187).
As a Medicare-enrolled provider, Somer has provided services to 1,395 Medicare beneficiaries, totaling 2,114 services with total Medicare billing of $167,976. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Camden, NJ
- Active Since 09/27/2006
- Last Updated 10/29/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1285725267
Products in Payments
- JEVTANA (Drug) $3,436
- ZOLADEX (Drug) $2,622
- PADCEV (Biological) $1,367
- KISQALI (Drug) $688.77
- FOUNDATIONACT (Device) $151.95
- FOUNDATIONONE LIQUID (Device) $151.95
- FIRMAGON (Drug) $138.86
- IMBRUVICA (Drug) $113.74
- Xtandi (Drug) $85.01
- ELIGARD (Drug) $79.81
- SUTENT (Drug) $60.70
- Cabometyx (Drug) $55.47
- TECENTRIQ (Biological) $49.70
- OPDIVO (Biological) $49.20
- DARZALEX (Biological) $48.61
- Xofigo (Drug) $48.55
- Avastin (Biological) $45.39
- Aranesp (Biological) $34.37
- Neulasta (Biological) $34.23
- ZEJULA (Drug) $33.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Camden
Dr. Ahmed Abou Hussein, M.d, M.D
Hematology & Oncology — Payments: $69,394
Hematology & Oncology $69,394
Generosa Grana, Md, MD
Hematology & Oncology — Payments: $43,127
Hematology & Oncology $43,127
Pallav Mehta, M.d, M.D
Hematology & Oncology — Payments: $38,998
Hematology & Oncology $38,998
Rabia Cattie, M.d, M.D
Hematology & Oncology — Payments: $20,384
Hematology & Oncology $20,384
Roger Strair, Md, MD
Hematology & Oncology — Payments: $16,825
Hematology & Oncology $16,825
Christina Clay, M.d, M.D
Hematology & Oncology — Payments: $14,860
Hematology & Oncology $14,860